Rybelsus vs. Farxiga

Reviewed on 12/16/2020

Are Rybelsus and Farxiga the Same Thing?

Rybelsus (semaglutide) and Farxiga (dapagliflozin) are used as adjuncts to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Rybelsus and Farxiga belong to different drug classes. Rybelsus is a glucagon-like peptide-1 (GLP-1) receptor agonist and Farxiga is a sodium-glucose co-transporter 2 (SGLT2) inhibitor.

Side effects of Rybelsus and Farxiga that are similar include nausea and constipation.

Side effects of Rybelsus that are different from Farxiga include abdominal pain, diarrhea, decreased appetite, and vomiting.

Side effects of Farxiga that are different from Rybelsus include yeast infections of the vagina or penis, urinary tract infections, changes in urination (including urgent need to urinate more often, discomfort when urinating, urinating in larger amounts, or at night), sore throat, runny or stuffy nose, back pain, influenza, elevated cholesterol or fat in the blood, and pain in the extremities.

Rybelsus may interact with insulin secretagogues or insulin, and other oral medications taken at the same time.

Farxiga may interact with other drugs.

What Are Possible Side Effects of Rybelsus?

Common side effects of Rybelsus include:

  • nausea,
  • abdominal pain,
  • diarrhea,
  • decreased appetite,
  • vomiting, and
  • constipation

What Are Possible Side Effects of Farxiga?

Common side effects of Farxiga include:

  • yeast infections of the vagina or penis,
  • urinary tract infections,
  • changes in urination (including urgent need to urinate more often, discomfort when urinating, urinating in larger amounts, or at night),
  • sore throat,
  • runny or stuffy nose,
  • back pain,
  • nausea,
  • influenza,
  • constipation,
  • elevated cholesterol or fat in the blood, or
  • pain in the extremities.

SLIDESHOW

Type 2 Diabetes: Signs, Symptoms, Treatments See Slideshow

What Is Rybelsus?

Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

What Is Farxiga?

Farxiga (dapagliflozin) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

What Drugs Interact With Rybelsus?

Farxiga may interact with other drugs. Tell your doctor all medications and supplements you use.

What Drugs Interact With Farxiga?

Farxiga may interact with monoamine oxidase inhibitors (MAOIs), opioid-containing medicines (such as cough and cold remedies, antidiarrheal drugs, and opioid analgesics), antidepressants, antipsychotics, beta-blockers, antiarrhythmics, ticlopidine, clopidogrel, ritonavir, lopinavir, efavirenz, theophylline, corticosteroids, levodopa, amantadine, and alcohol. Tell your doctor all medications and supplements you use. Farxiga is not recommended for use during pregnancy.

How Should Rybelsus be Taken?

The initial dose of Rybelsus is 3 mg once daily for 30 days. After 30 days on the 3 mg dose, increase the dose of Rybelsus to 7 mg once daily.

How Should Farxiga be Taken?

The recommended starting dose of Farxiga is 5 mg once daily, taken in the morning, with or without food.

QUESTION

______________ is another term for type 2 diabetes. See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Novo Nordisk. Rybelsus Product Information.

https://www.rybelsus.com/

AstraZeneca. Farxiga Product Information.

https://www.farxiga.com/

Health Solutions From Our Sponsors